Role of oxidative stress in the pathogenesis of sickle cell disease

被引:159
作者
Chirico, Erica N. [1 ]
Pialoux, Vincent [1 ]
机构
[1] Univ Lyon 1, EA 647, Ctr Rech & Innovat Sport, F-69622 Villeurbanne, France
关键词
nitric oxide; reactive oxygen species; hemoglobin; antioxidants; CHRONIC INTERMITTENT HYPOXIA; NITRIC-OXIDE SYNTHASE; ALPHA-LIPOIC ACID; PULMONARY-HYPERTENSION; ADHESION MOLECULE-1; ENDOTHELIAL-CELLS; ANEMIA PATIENTS; MICROVASCULAR DYSFUNCTION; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE;
D O I
10.1002/iub.584
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sickle cell disease (SCD) is a class of hemoglobinopathy in humans, which causes a disruption of the normal activities in different systems. Although this disease begins with the polymerization of red blood cells during its deoxygenating phase, it can erupt into a cascade of debilitating conditions such as ischemia-reperfusion injury, inflammation, and painful vaso-occlusion crises. The purpose of this review is to discuss how these phenomena can result in the formation of oxidative stress as well as limit nitric oxide (NO) bioavailability and decrease antioxidant status. The cumulative effects of these traits cause an increase in other forms of reactive oxygen species (ROS), which in turn intensify the symptoms of SCD and generate a vicious circle. Finally, we will discuss antioxidant therapeutic strategies that limit ROS generation and subsequently increase NO bioavailability with respect to endothelial protection in SCD. (C) IUBMB, IUBMB Life, 2011.
引用
收藏
页码:72 / 80
页数:9
相关论文
共 66 条
  • [1] Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants
    Amer, J
    Ghoti, H
    Rachmilewitz, E
    Koren, A
    Levin, C
    Fibach, E
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (01) : 108 - 113
  • [2] Aslan M, 2000, ANN NY ACAD SCI, V899, P375
  • [3] Redox-dependent impairment of vascular function in sickle cell disease
    Aslan, Mutay
    Freeman, Bruce A.
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2007, 43 (11) : 1469 - 1483
  • [4] Heme Degradation and Vascular Injury
    Belcher, John D.
    Beckman, Joan D.
    Balla, Gyorgy
    Balla, Jozsef
    Vercellotti, Gregory
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2010, 12 (02) : 233 - 248
  • [5] MOLECULAR AND CELLULAR PATHOGENESIS OF HEMOGLOBIN-SC DISEASE
    BUNN, HF
    NOGUCHI, CT
    HOFRICHTER, J
    SCHECHTER, GP
    SCHECHTER, AN
    EATON, WA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (23): : 7527 - 7531
  • [6] Erythroid adhesion molecules in sickle cell disease: Effect of hydroxyurea
    Cartron, J. -P.
    Elion, J.
    [J]. TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2008, 15 (1-2) : 39 - 50
  • [7] Nitric oxide from nitrite reduction by hemoglobin in the plasma and erythrocytes
    Chen, Kejing
    Piknova, Barbora
    Pittman, Roland N.
    Schechter, Alan N.
    Popel, Aleksander S.
    [J]. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2008, 18 (01): : 47 - 60
  • [8] PEROXIDATION, VITAMIN-E, AND SICKLE-CELL-ANEMIA
    CHIU, D
    VICHINSKY, E
    YEE, M
    KLEMAN, K
    LUBIN, B
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1982, 393 (SEP) : 323 - 335
  • [9] Newer Aspects of the Pathophysiology of Sickle Cell Disease Vaso-Occlusion
    Conran, Nicola
    Franco-Penteado, Carla F.
    Costa, Fernando F.
    [J]. HEMOGLOBIN, 2009, 33 (01) : 1 - 16
  • [10] Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia
    Cosentino, F.
    Huerlimann, D.
    Gatti, C. Delli
    Chenevard, R.
    Blau, N.
    Alp, N. J.
    Channon, K. M.
    Eto, M.
    Lerch, P.
    Enseleit, F.
    Ruschitzka, F.
    Volpe, M.
    Luescher, T. F.
    Noll, G.
    [J]. HEART, 2008, 94 (04) : 487 - 492